30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Aligos Therapeutics Inc (ALGS)

Track

Stock chart
Ticker: ALGS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Nuechterlein Carole
1 purchase — total 6,004,149 USD
Buy 25 Oct 2023
Value US$4,314,490.30 | Price 11.17 | Shares 76,402
Buy 20 Oct 2020
Value US$3,016,277.04 | Price 462.52 | Shares 30,973
Buy 20 Oct 2020
Value US$3,000,000.00 | Price 15.00 | Shares 200,000
Buy 20 Oct 2020
Value US$3,000,000.00 | Price 15.00 | Shares 200,000
Buy 20 Oct 2020
Value US$1,000,995.00 | Price 15.00 | Shares 66,733
Buy 20 Oct 2020
Value US$7,249,005.00 | Price 15.00 | Shares 483,267
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-27 2023-10-25 B Purchase
Nuechterlein Carole
Non-Executive Director Large shareholder
76,402 +2.1%
11.17
US$4,314,490 		76,402 +2.1% 11.17 US$4,314,490
2020-10-22 2020-10-20 B Purchase
2.3
Novo Holdings A/S
Large shareholder
30,973 +30.4%
462.52
US$3,016,277 		30,973 +30.4% 462.52 US$3,016,277
2020-10-20 2020-10-20 B Purchase
3.4
Woiwode Thomas
Non-Executive Director
83,694 -13.4%
467.89
US$4,563,346 		83,694 -13.4% 467.89 US$4,563,346
2020-10-20 2020-10-20 B Purchase
3.3
Versant Venture Capital VI, L.P.
Large shareholder
200,000 +30.2%
15.00
US$3,000,000 		200,000 +30.2% 15.00 US$3,000,000
2020-10-20 2020-10-20 B Purchase
2.4
Vivo Capital VIII, LLC
Large shareholder
66,733 +18.4%
15.00
US$1,000,995 		66,733 +18.4% 15.00 US$1,000,995
2020-10-20 2020-10-20 B Purchase
2.4
Vivo Capital VIII, LLC
Large shareholder
483,267 +18.4%
15.00
US$7,249,005 		483,267 +18.4% 15.00 US$7,249,005
Explore more

More insider trading research around Aligos Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America